Logo image of HASH.CA

SIMPLY SOLVENTLESS CONCENTRA (HASH.CA) Stock Fundamental Analysis

Canada - TSX Venture Exchange - TSX-V:HASH - CA82888A1021 - Common Stock

0.105 CAD
0 (0%)
Last: 12/24/2025, 7:00:00 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to HASH. HASH was compared to 30 industry peers in the Pharmaceuticals industry. Both the profitability and financial health of HASH have multiple concerns. HASH does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year HASH was profitable.
In the past year HASH has reported a negative cash flow from operations.
HASH.CA Yearly Net Income VS EBIT VS OCF VS FCFHASH.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 2024 0 2M -2M -4M -6M

1.2 Ratios

Looking at the Return On Assets, with a value of 6.91%, HASH belongs to the top of the industry, outperforming 86.67% of the companies in the same industry.
HASH has a better Return On Equity (13.05%) than 86.67% of its industry peers.
Industry RankSector Rank
ROA 6.91%
ROE 13.05%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HASH.CA Yearly ROA, ROE, ROICHASH.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2023 2024 0 10 -10 20 -20 -30

1.3 Margins

HASH's Profit Margin of 13.57% is amongst the best of the industry. HASH outperforms 86.67% of its industry peers.
HASH's Gross Margin of 28.99% is in line compared to the rest of the industry. HASH outperforms 43.33% of its industry peers.
Industry RankSector Rank
OM N/A
PM (TTM) 13.57%
GM 28.99%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HASH.CA Yearly Profit, Operating, Gross MarginsHASH.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 2024 0 20 -20 40

More info and screens

2

2. Health

2.1 Basic Checks

HASH does not have a ROIC to compare to the WACC, probably because it is not profitable.
HASH has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, HASH has a worse debt to assets ratio.
HASH.CA Yearly Shares OutstandingHASH.CA Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 20M 40M 60M 80M 100M
HASH.CA Yearly Total Debt VS Total AssetsHASH.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 10M 20M 30M

2.2 Solvency

HASH has an Altman-Z score of 1.14. This is a bad value and indicates that HASH is not financially healthy and even has some risk of bankruptcy.
HASH's Altman-Z score of 1.14 is fine compared to the rest of the industry. HASH outperforms 70.00% of its industry peers.
A Debt/Equity ratio of 0.38 indicates that HASH is not too dependend on debt financing.
HASH has a Debt to Equity ratio of 0.38. This is comparable to the rest of the industry: HASH outperforms 43.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Altman-Z 1.14
ROIC/WACCN/A
WACC8.04%
HASH.CA Yearly LT Debt VS Equity VS FCFHASH.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 2024 0 5M -5M 10M 15M

2.3 Liquidity

HASH has a Current Ratio of 2.53. This indicates that HASH is financially healthy and has no problem in meeting its short term obligations.
HASH has a Current ratio (2.53) which is in line with its industry peers.
HASH has a Quick Ratio of 2.53. This is a bad value and indicates that HASH is not financially healthy enough and could expect problems in meeting its short term obligations.
HASH's Quick ratio of 0.74 is on the low side compared to the rest of the industry. HASH is outperformed by 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.53
Quick Ratio 0.74
HASH.CA Yearly Current Assets VS Current LiabilitesHASH.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 5M 10M 15M 20M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for HASH have decreased strongly by -410.40% in the last year.
The Revenue has grown by 120.93% in the past year. This is a very strong growth!
EPS 1Y (TTM)-410.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-144.83%
Revenue 1Y (TTM)120.93%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%28.23%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
HASH.CA Yearly Revenue VS EstimatesHASH.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2M 4M 6M 8M 10M

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 5.25, the valuation of HASH can be described as very cheap.
Compared to the rest of the industry, the Price/Earnings ratio of HASH indicates a rather cheap valuation: HASH is cheaper than 93.33% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of HASH to the average of the S&P500 Index (26.92), we can say HASH is valued rather cheaply.
Industry RankSector Rank
PE 5.25
Fwd PE N/A
HASH.CA Price Earnings VS Forward Price EarningsHASH.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HASH.CA Per share dataHASH.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

HASH does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

SIMPLY SOLVENTLESS CONCENTRA

TSX-V:HASH (12/24/2025, 7:00:00 PM)

0.105

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-27 2025-11-27
Earnings (Next)04-28 2026-04-28
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners11.2%
Ins Owner ChangeN/A
Market Cap12.13M
Revenue(TTM)30.71M
Net Income(TTM)4.17M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 5.25
Fwd PE N/A
P/S 0.39
P/FCF N/A
P/OCF N/A
P/B 0.38
P/tB 0.61
EV/EBITDA N/A
EPS(TTM)0.02
EY19.05%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0.27
BVpS0.28
TBVpS0.17
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0.35
Profitability
Industry RankSector Rank
ROA 6.91%
ROE 13.05%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 13.57%
GM 28.99%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 2.7%
Cap/Sales 0.14%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.53
Quick Ratio 0.74
Altman-Z 1.14
F-Score4
WACC8.04%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-410.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-144.83%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)120.93%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%28.23%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-302.67%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1009.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1332.95%
OCF growth 3YN/A
OCF growth 5YN/A

SIMPLY SOLVENTLESS CONCENTRA / HASH.CA FAQ

What is the fundamental rating for HASH stock?

ChartMill assigns a fundamental rating of 2 / 10 to HASH.CA.


Can you provide the valuation status for SIMPLY SOLVENTLESS CONCENTRA?

ChartMill assigns a valuation rating of 2 / 10 to SIMPLY SOLVENTLESS CONCENTRA (HASH.CA). This can be considered as Overvalued.


How profitable is SIMPLY SOLVENTLESS CONCENTRA (HASH.CA) stock?

SIMPLY SOLVENTLESS CONCENTRA (HASH.CA) has a profitability rating of 3 / 10.


What is the financial health of SIMPLY SOLVENTLESS CONCENTRA (HASH.CA) stock?

The financial health rating of SIMPLY SOLVENTLESS CONCENTRA (HASH.CA) is 2 / 10.